Acquisitions

  • Novartis to buy cancer treatment developer MorphoSys for $2.9bn

    This week, Reuters reported that Swiss drugmaker Novartis AG said it will acquire German biotech MorphoSys AG, a developer of cancer treatments, for Euro2.7 billion (US$2.9 billion). The move by Novartis aims to add a promising rare bone marrow cancer treatment candidate to its portfolio. The companies said that shareholders of the German firm would…

    Read more →

  • The New York Times Co. is buying sports news site The Athletic for $550 million, the latest move in its strategy to expand its audience of paying subscribers as the newspaper print ads business fades. The Times, unlike many local news outlets, has thrived in the past several years. It gained millions of subscribers during…

    Read more →